These neutralizing antibodies are thought to inhibit viral infection by preventing the conformation change of the S protein either by locking the S protein in an intermediate conformation, by preventing S1 and S2-subunit cleavage, by targeting the fusion peptide or by stabilizing its pre-fusion conformation (73). The gene discussed is PROS1; the disease is viral infectious disease.